Wed, 09th Sep 2020 00:47
BRASILIA, Sept 8 (Reuters) - Brazil health regulator Anvisa
said on Tuesday that AstraZeneca PLC had announced the
suspension of global trials for a coronavirus vaccine, which
included a human trial being done in Brazil.
AstraZeneca had directly informed Anvisa about the
suspension, the regulator said, adding that it is waiting for
further details on the reason trials were stopped.
(Reporting by Ricardo Brito; writing by Jake Spring; Editing by
Sandra Maler)
(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump...
(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth readi...
(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover ta...
Q1 revenue up 19% to $12.68 bln *
(Alliance News) - AstraZeneca PLC on Thursday hailed the potential of its drugs pipeline as it delivered impressive growth in sales and profit in the ...
Astrazeneca (AZN)